|
|
||||||||
*

2,*
Department of
* Pathology, Michael Heidelberger Division of Immunology and Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, NY 10016;
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232; and
Department of Cell Biology and Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, NY 10016
Mice with fibroblast-specific expression of TAP-1 were generated by
expressing the TAP-1 transgene under the control of the
fibroblast-specific protein (FSP) 1 promoter/enhancer on
TAP-1-deficient background. MHC class I expression in primary
fibroblast cultures isolated from the resulting strain mimicked that of
wild-type counterparts. MHC class I was detected in both types of
fibroblasts following treatment with IFN-
. Positive selection of
CD4-CD8+ thymocytes was observed in neither
adult nor fetal/neonatal thymus of transgenic mice. IFN-
-induced
expression of MHC class I rescued positive selection of
CD4-CD8+ T cells in fetal thymic organ
cultures, but not in adult mice. Contrary to previous suggestions, our
results indicate a limited role of fibroblasts in promoting positive
selection. In addition, the results suggest that positive selection may
occur by a different mechanism in fetal vs adult
thymus.
This article has been cited by other articles:
![]() |
P. Osterloh, K. Linkemann, S. Tenzer, H.-G. Rammensee, M. P. Radsak, D. H. Busch, and H. Schild Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses PNAS, March 28, 2006; 103(13): 5042 - 5047. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Santori and S. Vukmanovic Delineation of Signals Required for Thymocyte Positive Selection J. Immunol., November 1, 2004; 173(9): 5517 - 5523. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Markert, M. Sarzotti, D. A. Ozaki, G. D. Sempowski, M. E. Rhein, L. P. Hale, F. Le Deist, M. J. Alexieff, J. Li, E. R. Hauser, et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients Blood, August 1, 2003; 102(3): 1121 - 1130. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |